NEWS

OHR Pharmaceutical provides update on ongoing squalamine clinical trial in WET-AMD

Tuesday, Apr 11, 2017

OHR Pharmaceutical provides update on ongoing squalamine clinical trial in Wet-Amd.

OHR Pharmaceutical Inc says company now fully funded through efficacy data from ongoing trial and into 2018.

OHR Pharmaceutical Inc says results from ongoing clinical trial in WET-AMD ( MAKO study) expected by end of calendar 2017 or early 2018.

 

Source: reuters.com

Other News